{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:30:28Z","timestamp":1790674228384,"version":"4.1.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T00:00:00Z","timestamp":1476230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["5T32DK060414\u201014"],"award-info":[{"award-number":["5T32DK060414\u201014"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK099253\u201001A1"],"award-info":[{"award-number":["DK099253\u201001A1"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK061713"],"award-info":[{"award-number":["U01DK061713"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK061718"],"award-info":[{"award-number":["U01DK061718"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK061728"],"award-info":[{"award-number":["U01DK061728"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK061730"],"award-info":[{"award-number":["U01DK061730"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK061731"],"award-info":[{"award-number":["U01DK061731"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK061732"],"award-info":[{"award-number":["U01DK061732"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK061734"],"award-info":[{"award-number":["U01DK061734"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK061737"],"award-info":[{"award-number":["U01DK061737"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK061738"],"award-info":[{"award-number":["U01DK061738"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["UL1TR000004"],"award-info":[{"award-number":["UL1TR000004"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["UL1TR000006"],"award-info":[{"award-number":["UL1TR000006"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["UL1TR000058"],"award-info":[{"award-number":["UL1TR000058"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["UL1TR000100"],"award-info":[{"award-number":["UL1TR000100"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["UL1TR000423"],"award-info":[{"award-number":["UL1TR000423"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["UL1TR000436"],"award-info":[{"award-number":["UL1TR000436"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["UL1TR000439"],"award-info":[{"award-number":["UL1TR000439"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["UL1TR000448"],"award-info":[{"award-number":["UL1TR000448"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1002\/hep.28776","type":"journal-article","created":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T18:52:50Z","timestamp":1471459970000},"page":"65-77","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":155,"title":["Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease"],"prefix":"10.1097","volume":"65","author":[{"given":"Veeral","family":"Ajmera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R.","family":"Perito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan M.","family":"Bass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah A.","family":"Terrault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine P.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Loomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Mae","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley E.","family":"Aouizerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20241017","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle\u2010aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"R2-14-20241017","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"R3-14-20241017","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/hep.21346","article-title":"Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease","volume":"44","author":"Merriman","year":"2006","journal-title":"Hepatology"},{"key":"R4-14-20241017","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000282083","article-title":"The role of cytokines in non\u2010alcoholic fatty liver disease","volume":"28","author":"Tilg","year":"2010","journal-title":"Dig Dis"},{"key":"R5-14-20241017","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2006.02.011","article-title":"Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2","volume":"44","author":"Haukeland","year":"2006","journal-title":"J Hepatol"},{"key":"R6-14-20241017","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2036.2007.03586.x","article-title":"Adipokines and cytokines in non\u2010alcoholic fatty liver disease","volume":"27","author":"Jarrar","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R7-14-20241017","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1478-3231.2005.01191.x","article-title":"Serum cytokine and soluble cytokine receptor levels in patients with non\u2010alcoholic steatohepatitis","volume":"26","author":"Abiru","year":"2006","journal-title":"Liver Int"},{"key":"R8-14-20241017","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2337\/db07-0156","article-title":"Genes involved in fatty acid partitioning and binding, lipolysis, monocyte\/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin\u2010resistant subjects","volume":"56","author":"Westerbacka","year":"2007","journal-title":"Diabetes"},{"key":"R9-14-20241017","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.20280","article-title":"Beyond insulin resistance in NASH: TNF\u2010alpha or adiponectin?","volume":"40","author":"Hui","year":"2004","journal-title":"Hepatology"},{"key":"R10-14-20241017","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1751-2980.2009.00386.x","article-title":"Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non\u2010alcoholic steatohepatitis","volume":"10","author":"Lesmana","year":"2009","journal-title":"J Dig Dis"},{"key":"R11-14-20241017","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/hep.21984","article-title":"Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European liver fibrosis panel and exploring simple markers","volume":"47","author":"Guha","year":"2008","journal-title":"Hepatology"},{"key":"R12-14-20241017","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/jc.2005-1056","article-title":"Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance","volume":"91","author":"Pagano","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R13-14-20241017","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cgh.2008.12.031","article-title":"Retinol\u2010binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease","volume":"7","author":"Nobili","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R14-14-20241017","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1046\/j.1365-2036.2001.01083.x","article-title":"Plasma transforming growth factor\u2010beta 1 level and efficacy of alpha\u2010tocopherol in patients with non\u2010alcoholic steatohepatitis: a pilot study","volume":"15","author":"Hasegawa","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"R15-14-20241017","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/hep.23784","article-title":"Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease","volume":"52","author":"Neuschwander\u2010Tetri","year":"2010","journal-title":"Hepatology"},{"key":"R16-14-20241017","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"key":"R17-14-20241017","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cct.2008.09.003","article-title":"Pioglitazone versus vitamin E versus placebo for the treatment of non\u2010diabetic patients with non\u2010alcoholic steatohepatitis: PIVENS trial design","volume":"30","author":"Chalasani","year":"2009","journal-title":"Contemp Clin Trials"},{"key":"R18-14-20241017","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"R19-14-20241017","doi-asserted-by":"crossref","first-page":"e2535","DOI":"10.1371\/journal.pone.0002535","article-title":"An evaluation of commercial fluorescent bead\u2010based luminex cytokine assays","volume":"3","author":"Djoba Siawaya","year":"2008","journal-title":"PLoS One"},{"key":"R20-14-20241017","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/cyto.b.20021","article-title":"Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers","volume":"61","author":"Khan","year":"2004","journal-title":"Cytometry B Clin Cytom"},{"key":"R21-14-20241017","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/hep.22724","article-title":"Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD\u2014clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network","volume":"49","author":"Brunt","year":"2009","journal-title":"Hepatology"},{"key":"R22-14-20241017","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1471-230X-6-34","article-title":"Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non\u2010alcoholic fatty liver disease","volume":"6","author":"Poynard","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"R23-14-20241017","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/hep.20223","article-title":"High sensitivity C\u2010reactive protein values do not reliably predict the severity of histological changes in NAFLD","volume":"39","author":"Hui","year":"2004","journal-title":"Hepatology"},{"key":"R24-14-20241017","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/hep.21998","article-title":"Noninvasive diagnosis of nonalcoholic fatty liver disease using serum biomarkers","volume":"46","author":"Mitry","year":"2007","journal-title":"Hepatology"},{"key":"R25-14-20241017","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.21223","article-title":"In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease","volume":"44","author":"Wieckowska","year":"2006","journal-title":"Hepatology"},{"key":"R26-14-20241017","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2013.07.042","article-title":"Limited value of plasma cytokeratin\u201018 as a biomarker for NASH and fibrosis in patients with non\u2010alcoholic fatty liver disease","volume":"60","author":"Cusi","year":"2014","journal-title":"J Hepatol"},{"key":"R27-14-20241017","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-0033-1334487","article-title":"Three decades of research on plasminogen activator inhibitor\u20101: a multifaceted serpin","volume":"39","author":"Declerck","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"R28-14-20241017","doi-asserted-by":"crossref","first-page":"15560","DOI":"10.1016\/S0021-9258(18)55433-8","article-title":"Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo","volume":"265","author":"Quax","year":"1990","journal-title":"J Biol Chem"},{"key":"R29-14-20241017","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1172\/JCI115440","article-title":"Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor\u2010alpha, and transforming growth factor\u2010beta","volume":"88","author":"Sawdey","year":"1991","journal-title":"J Clin Invest"},{"key":"R30-14-20241017","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.26510","article-title":"Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"59","author":"Verrijken","year":"2014","journal-title":"Hepatology"},{"key":"R31-14-20241017","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.2337\/dc07-0109","article-title":"Plasma PAI1 levels are increased in patients with nonalcoholic steatohepatitis","volume":"30","author":"Targher","year":"2007","journal-title":"Diabetes Care"},{"key":"R32-14-20241017","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1182\/blood.V70.4.1090.1090","article-title":"Conversion of the active to latent plasminogen activator inhibitor from human endothelial cells","volume":"70","author":"Levin","year":"1987","journal-title":"Blood"},{"key":"R33-14-20241017","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.ATV.0000077401.36885.BB","article-title":"Plasma PAI1 levels are more strongly related to liver steatosis than to adipose tissue accumulation","volume":"23","author":"Alessi","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R34-14-20241017","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0002-9343(99)00240-5","article-title":"Local insulin infusion stimulates expression of plasminogen activator inhibitor\u20101 and tissue\u2010type plasminogen activator in normal subjects","volume":"107","author":"Carmassi","year":"1999","journal-title":"Am J Med"},{"key":"R35-14-20241017","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1161\/01.ATV.19.6.1582","article-title":"Impact of adipose tissue on plasma plasminogen activator inhibitor\u20101 in dieting obese women","volume":"19","author":"Mavri","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R36-14-20241017","first-page":"2108","article-title":"Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-14-20241017","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1665-2681(19)31518-2","article-title":"Plasminogen activator inhibitor type 1 serum levels and 4G\/5G gene polymorphism in morbidly obese Hispanic patients with non\u2010alcoholic fatty liver disease","volume":"10","author":"Espino","year":"2011","journal-title":"Ann Hepatol"},{"key":"R38-14-20241017","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.atherosclerosis.2009.10.011","article-title":"Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease","volume":"209","author":"Sookoian","year":"2010","journal-title":"Atherosclerosis"},{"key":"R39-14-20241017","first-page":"3","article-title":"Insulin\u2010like growth\u2010factors and their binding\u2010proteins\u2014biological actions","volume":"16","author":"Jones","year":"1995","journal-title":"Endocr Rev"},{"key":"R40-14-20241017","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1210\/edrv-10-1-68","article-title":"Insulin\u2010like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations","volume":"10","author":"Daughaday","year":"1989","journal-title":"Endocr Rev"},{"key":"R41-14-20241017","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1432-1033.1978.tb12377.x","article-title":"Insulin\u2010like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin\u2010like activity of human serum","volume":"87","author":"Zapf","year":"1978","journal-title":"Eur J Biochem"},{"key":"R42-14-20241017","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.CIR.102.11.1296","article-title":"Adiponectin, an adipocyte\u2010derived plasma protein, inhibits endothelial NF\u2010kappaB signaling through a cAMP\u2010dependent pathway","volume":"102","author":"Ouchi","year":"2000","journal-title":"Circulation"},{"key":"R43-14-20241017","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat\u2010derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"R44-14-20241017","doi-asserted-by":"crossref","first-page":"E982","DOI":"10.1210\/jc.2011-3305","article-title":"Adiponectin as an independent predictor of the presence and degree of hepatic steatosis in the Dallas Heart Study","volume":"97","author":"Turer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R45-14-20241017","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3748\/wjg.v18.i8.727","article-title":"Role of cytokines and chemokines in non\u2010alcoholic fatty liver disease","volume":"18","author":"Braunersreuther","year":"2012","journal-title":"World J Gastroenterol"},{"key":"R46-14-20241017","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2036.2007.03586.x","article-title":"Adipokines and cytokines in non\u2010alcoholic fatty liver disease","volume":"27","author":"Jarrar","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R47-14-20241017","first-page":"1549","article-title":"Levels of serum hyaluronic acid, TNF\u2010alpha and IL\u20108 in patients with nonalcoholic steatohepatitis","volume":"52","author":"Bahcecioglu","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"R48-14-20241017","doi-asserted-by":"crossref","first-page":"G1281","DOI":"10.1152\/ajpgi.00074.2008","article-title":"Gene expression in human NAFLD","volume":"294","author":"Greco","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R49-14-20241017","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jhep.2009.10.035","article-title":"The hepatitis C virus core protein indirectly induces alpha\u2010smooth muscle actin expression in hepatic stellate cells via interleukin\u20108","volume":"52","author":"Cl\u00e9ment","year":"2010","journal-title":"J Hepatol"},{"key":"R50-14-20241017","doi-asserted-by":"crossref","first-page":"e21381","DOI":"10.1371\/journal.pone.0021381","article-title":"Interleukin\u20108 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis","volume":"6","author":"Zimmermann","year":"2011","journal-title":"PLoS One"},{"key":"R51-14-20241017","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1073\/pnas.85.9.3115","article-title":"Soluble interleukin 2 receptors are released from the cell surface of normal murine B lymphocytes stimulated with interleukin 5","volume":"85","author":"Loughnan","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"R52-14-20241017","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jaut.2009.09.010","article-title":"Serum inflammatory cytokines, complement components, and soluble interleukin 2 receptor in primary biliary cirrhosis","volume":"33","author":"Barak","year":"2009","journal-title":"J Autoimmun"},{"key":"R53-14-20241017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-12-38","article-title":"Elevated circulating soluble interleukin\u20102 receptor in patients with chronic liver diseases is associated with non\u2010classical monocytes","volume":"12","author":"Seidler","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"R54-14-20241017","first-page":"245","article-title":"Increased serum soluble interleukin 2 receptor levels in patients with viral liver diseases","volume":"35","author":"Yamaguchi","year":"1988","journal-title":"Hepatogastroenterology"},{"key":"R55-14-20241017","first-page":"949","article-title":"Serum IGF\u20101, IGF\u20102 and IGFBP\u20103 as parameters in the assessment of liver dysfunction in patients with hepatic cirrhosis and in the diagnosis of hepatocellular carcinoma","volume":"58","author":"Rehem","year":"2011","journal-title":"Hepatogastroenterology"},{"key":"R56-14-20241017","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpeds.2014.01.052","article-title":"Insulin\u2010like growth factor\u2010I and \u2010II levels are associated with the progression of nonalcoholic fatty liver disease in obese children","volume":"165","author":"Cianfarani","year":"2014","journal-title":"J Pediatr"},{"key":"R57-14-20241017","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1479-5876-9-123","article-title":"Liver mitochondrial dysfunction is reverted by insulin\u2010like growth factor II (IGF\u2010II) in aging rats","volume":"9","author":"Garcia\u2010Fernandez","year":"2011","journal-title":"J Transl Med"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.28776","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.28776","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.28776","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep.28776","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201701000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T18:41:23Z","timestamp":1729190483000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201701000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.28776","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}